BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26466221)

  • 21. [Statins and the risk of diabetes].
    Simonyi G
    Orv Hetil; 2013 Oct; 154(43):1691-5. PubMed ID: 24140507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of statin use with glycaemic traits and incident type 2 diabetes.
    Ahmadizar F; Ochoa-Rosales C; Glisic M; Franco OH; Muka T; Stricker BH
    Br J Clin Pharmacol; 2019 May; 85(5):993-1002. PubMed ID: 30838685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
    van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
    Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins and the potential for higher diabetes mellitus risk.
    Yandrapalli S; Malik A; Guber K; Rochlani Y; Pemmasani G; Jasti M; Aronow WS
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):825-830. PubMed ID: 31474169
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathophysiological aspects of the diabetogenic effect of statins].
    Pilemann-Lyberg S; Solis AB; Gæde P
    Ugeskr Laeger; 2014 Feb; 176(3):223-7. PubMed ID: 24629748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association of Statin Therapy with Incident Diabetes: Evidence, Mechanisms, and Recommendations.
    Agarwala A; Kulkarni S; Maddox T
    Curr Cardiol Rep; 2018 May; 20(7):50. PubMed ID: 29779165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins and diabetes.
    Maki KC; Dicklin MR; Baum SJ
    Cardiol Clin; 2015 May; 33(2):233-43. PubMed ID: 25939296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and new-onset diabetes.
    Barylski M; Nikolic D; Banach M; Toth PP; Montalto G; Rizzo M
    Curr Pharm Des; 2014; 20(22):3657-64. PubMed ID: 24040871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin-Associated Diabetes Mellitus: Review and Clinical Guide.
    Backes JM; Kostoff MD; Gibson CA; Ruisinger JF
    South Med J; 2016 Mar; 109(3):167-73. PubMed ID: 26954655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins are diabetogenic--myth or reality?
    Sattar N; Taskinen MR
    Atheroscler Suppl; 2012 Aug; 13(1):1-10. PubMed ID: 22818818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults.
    Mansi I; Frei CR; Wang CP; Mortensen EM
    J Gen Intern Med; 2015 Nov; 30(11):1599-610. PubMed ID: 25917657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins and diabetes risk: fact, fiction, and clinical implications.
    Rocco MB
    Cleve Clin J Med; 2012 Dec; 79(12):883-93. PubMed ID: 23208994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin use and the risk of incident diabetes mellitus: a review of the literature.
    Colbert JD; Stone JA
    Can J Cardiol; 2012; 28(5):581-9. PubMed ID: 22658337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
    Minder CM; Blumenthal RS; Blaha MJ
    Curr Opin Cardiol; 2013 Sep; 28(5):554-60. PubMed ID: 23928920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diabetogenic action of statins - mechanisms and clinical implications.
    Betteridge DJ; Carmena R
    Nat Rev Endocrinol; 2016 Feb; 12(2):99-110. PubMed ID: 26668119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 39. Statin use and risk for type 2 diabetes: what clinicians should know.
    Maki KC; Diwadkar-Navsariwala V; Kramer MW
    Postgrad Med; 2018 Mar; 130(2):166-172. PubMed ID: 29139315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
    Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.